Cargando…
Molecular targeting of renal cell carcinoma by an oral combination
The 5-year survival rate of patients with metastatic renal cell carcinoma (mRCC) is <12% due to treatment failure. Therapeutic strategies that overcome resistance to modestly effective drugs for mRCC, such as sorafenib (SF), could improve outcome in mRCC patients. SF is terminally biotransformed...
Autores principales: | Jordan, Andre R., Wang, Jiaojiao, Yates, Travis J., Hasanali, Sarrah L., Lokeshwar, Soum D., Morera, Daley S., Shamaladevi, Nagarajarao, Li, Charles S., Klaassen, Zachary, Terris, Martha K., Thangaraju, Muthusamy, Singh, Amar B., Soloway, Mark S., Lokeshwar, Vinata B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7237463/ https://www.ncbi.nlm.nih.gov/pubmed/32427869 http://dx.doi.org/10.1038/s41389-020-0233-0 |
Ejemplares similares
-
Targeting hyaluronic acid synthase-3 (HAS3) for the treatment of advanced renal cell carcinoma
por: Wang, Jiaojiao, et al.
Publicado: (2022) -
Hyaluronic acid family in bladder cancer: potential prognostic biomarkers and therapeutic targets
por: Morera, Daley S, et al.
Publicado: (2017) -
Molecular Oncology of Bladder Cancer from Inception to Modern Perspective
por: Lokeshwar, Soum D., et al.
Publicado: (2022) -
The andean anticancer herbal product BIRM causes destabilization of androgen receptor and induces caspase-8 mediated-apoptosis in prostate cancer
por: Shamaladevi, Nagarajarao, et al.
Publicado: (2016) -
The Effect of Bupivacaine on the Efficacy of Antibiotic Coating on Penile Implants in Preventing Infection
por: Lokeshwar, Soum D., et al.
Publicado: (2019)